Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Gross Profit: 2019-2024

Historic Gross Profit for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to $10.0 million.

  • Caribou Biosciences' Gross Profit rose 8.60% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 19.00%. This contributed to the annual value of $10.0 million for FY2024, which is 71.01% down from last year.
  • Latest data reveals that Caribou Biosciences reported Gross Profit of $10.0 million as of FY2024, which was down 71.01% from $34.5 million recorded in FY2023.
  • In the past 5 years, Caribou Biosciences' Gross Profit registered a high of $34.5 million during FY2023, and its lowest value of $9.6 million during FY2021.
  • Its 3-year average for Gross Profit is $19.4 million, with a median of $13.9 million in 2022.
  • As far as peak fluctuations go, Caribou Biosciences' Gross Profit surged by 148.91% in 2023, and later slumped by 71.01% in 2024.
  • Over the past 5 years, Caribou Biosciences' Gross Profit (Yearly) stood at $12.4 million in 2020, then decreased by 22.35% to $9.6 million in 2021, then spiked by 44.31% to $13.9 million in 2022, then skyrocketed by 148.91% to $34.5 million in 2023, then plummeted by 71.01% to $10.0 million in 2024.